Masimo | MASI - Cost Of Sales


Masimo reported $165.2M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 363.97M 7.48M Dec/2025
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.83B 8M Mar/2026
Dexcom USD 466.9M 11M Dec/2025
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
General Electric Aerospace USD 8.15B 764M Mar/2026
Globus Medical USD 290.47M 8.09M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
Intuitive Surgical USD 940.3M 21.6M Mar/2026
Masimo USD 165.2M 24.3M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Orthofix International USD 66.63M 6.4M Dec/2025
Owens Minor USD 436.92M 32.62M Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025